Mittwoch, 29. Oktober 2014

Allergan's VISTABEL® (Botulinum Toxin Type A) Receives Europe's First Positive Opinion for Treatment of Moderate to Seve...
MARLOW, England, October 23, 2013 /PRNewswire/ - Positive Opinion Paves the Way for a Second Aesthetic Indication for VISTABEL® in 29 European Countries Today, Allergan Inc. announced that VISTABEL® has received a Positive Opinion from the Agence …
Source:


Gesichtsmodellierung

Keine Kommentare:

Kommentar veröffentlichen